At CPHI Japan 2025 Nirav K Shah, Vice President, Head API – North Asia, participated in an exhibitor showcase session entitled 'The Role of ESG Standards in Robust API and Formulation Supply'. His session sparked engaging conversations around how ESG principles are becoming foundational to building resilient, responsible, and future-ready pharma supply chains. It was an incredible opportunity to share how Dr. Reddy’s is setting new benchmarks in sustainable API and formulation supply.
No information on this website, including any reference to any product or service constitutes an offer for sale or be construed as representing an offer for sale. Products protected under valid patents are not offered or supplied for commercial use. However, in certain cases, at Dr. Reddy's sole discretion, and subject to local legal requirement, the research quantities of such products may be offered for the purpose of regulatory submissions under Section 107A of the Indian Patent Act (Bolar exemption), wherever such regulatory exemptions exist. The buyers should make their independent evaluation of the product or service including, patent scenario in their respective markets and will be responsible for all patent related liabilities Dr. Reddy's disclaims all warranties, express or implied, including but not limited to warranties of merchantability, fitness for a particular purpose and non-infringement.